![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, October 04, 2018 1:59:11 AM
https://www.immunetherapeutics.com/2018/03/immune_therapeutics_inc_received_minutes_from_fda_meeting_for_lodonal_for_the_treatment_for_crohns_disease/
https://www.immunetherapeutics.com/2017/09/immune-therapeutics-inc-announces-exclusive-agreement-for-sale-of-lodonal-in-kenya-valued-at-over-31-million/
https://www.immunetherapeutics.com/2017/11/immune-therapeutics-inc-shareholder-update-letter/
https://www.immunetherapeutics.com/project/lodonal-kenya/
https://www.immunetherapeutics.com/project/china-car-t/
https://www.immunetherapeutics.com/project/malawi-medical-equipment-donation/
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM